🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial is divided in two parts, Part A and Part B. Part A will involve d...
Status
Completed
Location
1200.122.33001 Boehringer Ingelheim Investigational Site
Start Date
2013-12
Trial ID
NCT02020577
Treatments Being Tested
A Phase 1/2 multi-center open-label study of BGB324 (bemcentinib) as a sing...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2015-04-19
Trial ID
NCT02424617
Treatments Being Tested
Trial Objectives: The objective is to investigate the efficacy and safety ...
Status
Terminated
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2012-12
Trial ID
NCT01732640
Treatments Being Tested
Global, Phase 3, randomized, multicenter, open-label study evaluating the e...
Status
Recruiting
Location
St. Jude Medical Center
Start Date
2025-12-17
Trial ID
NCT07185997
Treatments Being Tested
The investigators are doing this research program to find out if the invest...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-05-29
Trial ID
NCT02274012
Treatments Being Tested
The primary objective of this trial is to explore the efficacy of BIBW 2992...
Status
Completed
Location
1200.11.3 Boehringer Ingelheim Investigational Site
Start Date
2006-09
Trial ID
NCT00431067
Treatments Being Tested
Patients will receive AZD9291 at a dose of 80 mg once daily. Intracranial r...
Status
Unknown
Location
Shaare Zedek
Start Date
2016-05
Trial ID
NCT02736513
Treatments Being Tested
This is a randomised, open-label, phase IIb trial of afatinib to compare to...
Status
Completed
Location
Chris Obrien Lifehouse
Start Date
2011-12-13
Trial ID
NCT01466660
The purpose of this study is to: * Find out if the study drugs Afatinib an...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2013-12-31
Trial ID
NCT01999985
Treatments Being Tested
Afatinib is an irreversible ErbB-family blocker with approved clinical acti...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2018-04-15
Trial ID
NCT03486587
Treatments Being Tested